One-stop hybrid coronary revascularization versus coronary artery bypass graft and percutaneous coronary intervention for the treatment of multivessel coronary artery disease
Background One-stop hybrid coronary revascularization (HCR) has emerged to be a feasible and attractive alternative to coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) in selected patients with multivessel coronary artery disease.This study sought to compare midterm clinical outcomes and cost effectiveness of one-stop HCR with CABG and PCI for the treatment ofmultivessel coronary artery disease.
HU Sheng-shou SHEN Liu-zhong XIONG Hui ZHENG Zhe LI Li-huan XU Bo GAO Run-lin
National Center for Cardiovascular Disease,China & Fuwai Hospital Beijing 100037,China
国内会议
北京
英文
10-10
2013-03-20(万方平台首次上网日期,不代表论文的发表时间)